Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 61
Filter
2.
Braz. dent. j ; 34(4): 143-149, July-Aug. 2023. tab, graf
Article in English | LILACS-Express | LILACS, BBO | ID: biblio-1520329

ABSTRACT

Abstract Orthodontics patients usual develop demineralization and present cavity caries lesions after six months. Minimally invasive procedures have been the goal in modern dental practice. The aim of this study was to evaluate the effect of ClinproTMXT Varnish, on the enamel surface roughness and severity of white spot lesions. Twenty premolars were submitted to bond brackets and experimental induction of demineralization and randomly divided into 2 groups: GI - fluoride varnish (Colgate Duraphat®); GII - Ionomeric Sealant (ClinproTMXT Varnish). The treatment was applied around the brackets. The surface roughness of specimens was analyzed, before treatment and 12 weeks after treatment by laser confocal microscopy, and the severity of the white spot lesion was by laser fluorescence device. The data were analyzed by non-parametric Wilcoxon and Mann-Whitney Test, at 5% significance, roughness percentage reduction was performed. The severity of demineralization decreased in both, GI (p = 0.005) and GII (p = 0.019). Enamel superficial roughness levels decreased in GI and GII. As well as the roughness percentage, being more expressive in the ClinproTMXT Varnish group (85,09%). Colgate Duraphat® or Clinpro™ XT Varnish reduced the severity of the demineralization and decreased the superficial roughness on the enamel. The Clinpro™ XT Varnish was superior to superficial roughness on enamel.


Resumo Pacientes ortodônticos geralmente desenvolvem desmineralização e apresentam lesões de cárie após seis meses de tratamento. Procedimentos minimamente invasivos têm sido o objetivo na prática odontológica moderna. O objetivo deste estudo foi avaliar o efeito do ClinproTM XT selante ionomérico, ao redor do bráquete, com relação a rugosidade superficial do esmalte e a severidade da lesão induzida. Vinte pré-molares foram submetidos a colagem de bráquetes e indução experimental de desmineralização e divididos aleatoriamente em 2 grupos: GI - verniz fluoretado (Colgate Duraphat®); GII - Selante Ionomérico (ClinproTM XT). O tratamento foi aplicado ao redor dos bráquetes. A rugosidade da superfície dos espécimes foi analisada, antes do tratamento e 12 semanas após o tratamento por microscopia confocal a laser e severidade da lesão de mancha branca por dispositivo de fluorescência a laser. Os dados foram analisados pelo teste não paramétrico de Wilcoxon e Mann-Whitney, a 5% de significância. A taxa de redução da lesão foi calculada. A severidade da desmineralização diminuiu tanto no GI (p = 0,005) quanto no GII (p = 0,019). Os níveis de rugosidade superficial do esmalte diminuíram no GI e GII, assim como o percentual de rugosidade, sendo mais expressivo no grupo ClinproTMXT (85,09%). Colgate Duraphat® e Clinpro™ XT reduziram a severidade da desmineralização e diminuíram a rugosidade superficial do esmalte. O selante ionomérico Clinpro™ XT foi superior na redução percentual de rugosidade.

3.
J. appl. oral sci ; 31: e20230100, 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1448549

ABSTRACT

Abstract Despite the recognized impact of diet on non-communicable diseases, the association between the Mediterranean diet and periodontal diseases is still uncertain. This study aimed to determine the association between adherence to the Mediterranean Diet Index (MDI) and self-reported gingival health status in Chilean adults, exploring the feasibility of using validated web-based survey questionnaires. Methodology Cross-sectional data were collected from a representative sample of a population of Chilean adults (18-60 years old) using a low-cost and time-saving methodology. By the PsyToolkit platform, anonymous survey data were downloaded and analyzed in bivariate (crude) and backward stepwise selection multivariate logistic regression models adjusted for sociodemographic determinants, smoking, and dental attendance using STATA 17. Odds ratios (OR) [95% confidence intervals] were estimated. Results In total, 351 complete statistical data were mostly obtained from female university students who had never smoked and reported having visited a dentist in the previous year. Multivariate regression models showed an association between MDI and very good/good gingival health status (OR 1.18 [95% CI 1.04-1.34], p=0.013), absence of bleeding on toothbrushing (OR 1.12 [95% CI 1.01-1.25], p=0.035), and absence of clinical signs of gingival inflammation (OR 1.24 [95% CI 1.10-1.40], p<0.001), after controlling for age, sex, educational level, smoking, and dental attendance. Conclusions We associated adherence to the Mediterranean diet with better self-reported gingival health status in a population of Chilean adults in an entirely web-based research environment. Longitudinal studies with random sampling are required to establish the effect of diet on gingival and periodontal health. Nevertheless, this evidence could contribute to the design of low-cost surveillance programs to reduce the burden of periodontal disease and related "common risk factors".

4.
Rev. chil. obstet. ginecol. (En línea) ; 87(5): 333-349, oct. 2022. ilus, tab
Article in Spanish | LILACS | ID: biblio-1423737

ABSTRACT

La patología mamaria durante el embarazo y la lactancia representa un desafío debido a que los cambios fisiológicos del tejido mamario durante este periodo pueden afectar la interpretación de los hallazgos clínicos e imagenológicos. El objetivo de esta revisión es conocer el diagnóstico diferencial de las enfermedades mamarias durante el embarazo y la lactancia. La mayoría de las patologías mamarias durante el embarazo y la lactancia son benignas y pueden ser clasificadas en tres categorías: 1) aquellas relacionadas con cambios fisiológicos, 2) enfermedades inflamatorias y 3) tumores benignos. Solo el 3% de los cánceres mamarios se desarrollan durante el embarazo. Los factores de mal pronóstico, como receptores hormonales negativos o HER2/neu positivo, en las mujeres embarazadas tienen una prevalencia similar a la observada en no embarazadas de la misma edad. El diagnóstico precoz es de crucial importancia pronóstica, por lo que es necesario mantener los esquemas de tamizaje recomendados. Es importante estar familiarizado con los cambios fisiológicos durante el embarazo y la lactancia, y conocer las patologías más prevalentes que afectan a las mujeres durante este periodo.


Breast pathology throughout pregnancy and lactation represents a challenge because the physiological changes of mammary tissue during this period may affect the interpretation of clinical and imaging findings. The objective of this presentation is to review the differential diagnosis of breast diseases during pregnancy and lactation. Most of breast pathology during pregnancy and lactation is benign and can be further classified into three categories: 1) those related to physiological changes, 2) inflammatory diseases, and 3) benign tumors. Only 3% of breast cancers will develop during pregnancy. Risk factors for worst prognosis, such as negative hormonal receptors or HER2/neu positive, in pregnant women have similar prevalence than in non-pregnant women of the same age. Early diagnose is of the outmost prognostic importance, therefore it`s important to maintain screening schedule as recommended. It is important to be familiarized with the physiological changes of the breast during pregnancy and lactation, and to know the most prevalent diseases affecting women during this period.


Subject(s)
Humans , Female , Pregnancy , Breast Diseases/diagnostic imaging , Breast Feeding , Mammography , Mass Screening , Ultrasonography, Mammary , Diagnosis, Differential
5.
Rev. sanid. mil ; 76(1): e02, ene.-mar. 2022. graf
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1432121

ABSTRACT

Resumen Paciente de 69 años con antecedentes de diabetes, hipertensión arterial y EPOC, presenta alteraciones del estado neurológico focal y del estado de alerta, que corresponde inicialmente con un coma diabético y tensión arterial elevada, posteriormente con dificultad para elevar el párpado derecho, realizándose tomografía de cráneo, resonancia magnética de cráneo y exámenes de laboratorio. Tomografía de cráneo con reporte de hallazgos indirectos de trombosis vs. tromboflebitis del seno cavernoso caracterizado por ptosis derecha con incremento de la densidad de la grasa intraconal, edema de los músculos extraconales, abombamiento del seno cavernoso de predominio izquierdo, zona de infarto en giros frontobasales, proceso inflamatorio en la mucosa nasal de cavidades paranasales. Resonancia magnética de cráneo con reporte de abscesos parenquimatosos de localización frontobasal bilateral que se asocia a proceso inflamatorio e infeccioso etmoidal bilateral y miositis del oblicuo superior derecho.


Summary Patient of 69 years with a history of diabetes, arterial hypertension and COPD, showing conscious and focal alterations of the neurologic state, which at a beginning correspond to a diabetic comma and elevated blood pressure with difficulty to elevate the right eyelid, cranium tomography, cranium magnetic resonance and laboratory tests are run. The tomography shows findings of thrombosis vs. thrombophlebitis of the venous sinus characterized by right ptosis with increment of the intraconal fat density, extraconal muscle edema, predominantly left bulging of the venous sinus, infarct on the frontobasal gyrus. Inflammatory process of the nasal mucosa of paranasal cavities. Cranium magnetic resonance bilateral frontobasal parenchimal abscesses are reported, associated to bilateral etmoidal inflammatory and infectious process and myositis of the upper right oblicuos.

6.
Braz. dent. j ; 33(1): 41-56, jan.-fev. 2022. tab, graf
Article in English | LILACS-Express | LILACS, BBO | ID: biblio-1364481

ABSTRACT

Abstract The aim of this study was to evaluate the subcutaneous connective tissue response of isogenic mice exposed to tricalcium silicate (Biodentine) and aggregated mineral trioxide (ProRoot MTA). A total of 120 mice were divided into 4 groups in 3 different experimental periods (7, 21 and 63 days): Biodentine; Pro-Root MTA; zinc oxide-eugenol and; Negative control - Sham. After the experimental periods microscopic descriptive, semi-quantitative and quantitative analysis of the inflammatory process were analyzed on H&E sections and evaluation of the gene expression of Il10, Infg, Il6, Il1r1 and Tnf (qRT-PCR) were performed. The data obtained were analyzed using the chi-square test and two-way analysis of variance (ANOVA) followed by the Bonferroni post-test (5% significance level). Results: In the microscopic analysis, a slight inflammatory infiltrate was observed, with a predominance of sparse macrophages and polymorphonuclear cells, slight tissue fibrosis, regular fibrous capsule and with dystrophic calcifications, in all groups that received the materials (Biodentine and Pro-Root MTA). In parallel, all materials modulated the gene expression of the different cytokines and receptors evaluated. Conclusion: Pro-Root MTA and Biodentine showed a tissue compatibility, mediated inflammation, with increased fibrous tissue and production of pro- and anti-inflammatory cytokines.


Resumo Objetivo: Avaliar a resposta do tecido conjuntivo subcutâneo de camundongos isogênicos expostos à Biodentine™ e ao Trióxido Mineral Agregado (MTA). Métodos: Um total de 120 camundongos foram divididos em 4 grupos e 3 períodos experimentais diferentes (7, 21 e 63 dias): Biodentine™ (Septodont, Saint Maur des Fosses, França); Pro-Root MTA (Dentsplay, Tulsa, EUA); óxido de zinco eugenol (Biodinâmica Química e Farmacêutica LTDA., Ibiporã, PR - Brasil); e controle negativo - Sham. Após os períodos experimentais, análises microscópicas descritivas, semiquantitativas e quantitativas do processo inflamatório foram analisadas nos cortes de H&E e ainda, foi realizada a avaliação da expressão gênica de Il10, Infg, Il6, Il1r1 e Tnf (qRT-PCR). Os dados obtidos foram analisados por meio do teste do qui-quadrado e da análise de variância (ANOVA) two-way, seguido do pós-teste de Bonferroni (nível de significância de 5%). Resultados: Na análise microscópica observou-se discreto infiltrado inflamatório, com predomínio de macrófagos esparsos e polimorfonucleares, leve fibrose tecidual, cápsula fibrosa regular e com calcificações distróficas, em todos os grupos que receberam os materiais (Biodentine ™ e Pro-Root MTA). Paralelamente, todos os materiais modulam a expressão gênica das diferentes citocinas e receptores avaliados. Conclusão: Pro-Root MTA e Biodentine™ mostraram compatibilidade tecidual, inflamação mediada, com aumento do tecido fibroso e produção de citocinas pró- e antiinflamatórias.

7.
Int. j. morphol ; 39(6): 1673-1676, dic. 2021. ilus
Article in Spanish | LILACS | ID: biblio-1385547

ABSTRACT

RESUMEN: El nervio femoral (NF) es el mayor o ramo del plexo lumbar. Normalmente se origina de las divisiones posteriores del segundo al cuarto ramo anterior del plexo lumbar (L2-L4). El músculo psoas mayor tiene su origen a nivel de las vértebras T12 a L5, se fusiona con el músculo ilíaco para luego insertarse en el trocánter menor del fémur. Normalmente, a nivel de la pelvis menor el NF se encuentra entre los músculos ilíaco y psoas mayor. En este trabajo presentamos un caso donde el músculo psoas mayor se relaciona con divisiones o split del NF, esta es una rara variación en la división y curso del NF con relación al músculo psoas mayor. Se observó que el NF se dividía en dos ramos por sobre el plano del ligamento inguinal después de su origen en el plexo lumbar. El NF del lado izquierdo se formó por las ramas ventrales de L2 a L4, a nivel de L5 el nervio es perforado por fascículos del músculo psoas mayor. La división inferior del NF pasaba profundamente a las fibras del músculo iliopsoas y la división superior pasaba superficialmente al músculo psoas mayor y profundo a la fascia ilíaca. Después de un trayecto de 60,21 mm ambas divisiones se unieron, después de atrapar fibras músculo iliopsoas justo inmediatamente proximal al ligamento inguinal para formar el tronco del NF. Si bien las causas embriológicas de las variaciones de los nervios periféricos se remontan a la quinta y sexta semana de vida intrauterina, la expresión clínica de disfunciones neuromusculares aparecerá varios decenios después. De modo que los médicos de las áreas de la traumatología y neurología deben estar al tanto de tales variantes anatómicas para entender mejor el dolor y los síndromes asociados a la compresión nerviosa y durante las maniobras quirúrgicas en esta región.


SUMMARY: AbstractThe femoral nerve (NF) is the major branch (or ramus) of the lumbar plexus. It normally originates from the posterior divisions of the second to fourth anterior branches of the lumbar plexus (L2-L4). The psoas major muscle originates at the level of the T12 to L5 vertebrae, fuses with the iliacus muscle and then inserts into the lesser trochanter of the femur. Normally, at the level of the lesser pelvis, the NF is found between the iliacus and psoas major muscles. In this paper we present a case where the psoas major muscle is related to divisions or splitting of the NF, this is a rare variation in the division and course of the NF in relation to the psoas major muscle. The NF was observed to divide into two branches above the plane of the inguinal ligament after its origin in the lumbar plexus. The NF on the left side was formed by ventral branches from L2 to L4, at the level of L5 the nerve is perforated by fascicles of the psoas major muscle. The lower division of the NF passed deep to the fibers of the iliopsoas muscle and the upper division passed superficial to the psoas major muscle and deep to the iliac fascia. After a path of 60.21 mm both divisions joined, after trapping iliopsoas muscle fibers just immediately proximal to the inguinal ligament to form the NF trunk. While the embryological causes of peripheral nerve variations date back to the fifth and sixth week of intrauterine life, the clinical expression of neuromuscular dysfunctions will appear several decades later. Thus, physicians in the areas of traumatology and neurology should be aware of such anatomical variants to better understand pain and syndromes associated with nerve compression and during surgical maneuvers in this region.


Subject(s)
Humans , Male , Adult , Psoas Muscles/innervation , Femoral Nerve/anatomy & histology , Cadaver , Anatomic Variation
8.
Braz. dent. j ; 32(1): 48-52, Jan.-Feb. 2021. graf
Article in English | LILACS, BBO | ID: biblio-1180718

ABSTRACT

Abstract This study evaluated the cytotoxicity of Sealapex Xpress and Real Seal XT and their effect on macrophage activation. J774.1 macrophages were incubated with Sealapex Xpress and Seal Real XT (0.1, 1.0, and 10 mg/mL) for 24 and 48 h. Cell viability was assessed by the MTT assay and macrophage activation was measured by pro- and anti-inflammatory cytokine production using ELISA. Data were analyzed using one-way ANOVA and Tukey's post-test (a=0.05). Cell viability was not affected with 0.1 or 1.0 mg/mL of extracts of Sealapex Xpress and Real Seal XT at 24 and 48 h (p>0.05), but was significantly lower when cells were exposed to 10 mg/mL of both sealers (p<0.05). Sealapex Xpress inhibited the production of TNF-a, whereas Real Seal XT induced TNF-a secretion at 24 h (p<0.05). IL-6 production was induced by Real Seal XT, but not by Sealapex Xpress (p<0.05). Real Seal XT and Sealapex Xpress induced the secretion of anti-inflammatory IL-10. IL-4 was not detected in any group. In conclusion, both sealers had low toxicity but differentially activated macrophages. Macrophage activation by Sealapex Xpress was characterized by inhibition of TNF-a and induction of IL-10, whereas Real Seal XT induced IL-6 solely.


Resumo O objetivo deste estudo foi avaliar in vitro a citotoxicidade dos cimentos endodônticos Sealapex Xpress e Real Seal XT pelo ensaio de MTT e a ativação de macrófagos J774.1. Os cimentos endodônticos Sealapex Xpress e Real Seal XT foram pesados e os extratos foram obtidos a partir da diluição em meio de cultura DMEM por 48 horas (10mg/mL, 1mg/m, e 0,1 mg/mL). A viabilidade celular foi avaliada pelo ensaio MTT e a produção de citocinas (TNF-a, IL-6 e IL-10) foi investigada pelo ensaio imunoenzimático (ELISA) em células de linhagem (macrofagos J774.1). Os dados obtidos foram analisados utilizando-se análise de variância de uma via e pós-teste de Tukey (a=0,05). A viabilidade celular após 24 ou 48 horas não foi afetada nas concentrações de 0,1 ou 1 mg/mL dos dois cimentos estudados (p>0,05). Por outro lado, na concentração 10 mg/mL, a viabilidade celular foi significativamente mais baixa (p <0,05). Observou-se que o Sealapex Xpress inibiu a produção de TNF-a, enquanto o Real Seal XT induziu a secreção de TNF-a às 24 h (p<0,05). A produção de IL-6 foi induzida pelo Real Seal XT, mas não pelo Sealapex Xpress (p<0,05). A secreção da citocina anti-inflamatória IL-10 foi induzida tanto pelo Real Seal XT quanto pelo Sealapex Xpress. IL-4 não foi detectada em nenhum grupo. Em conclusão, os dois cimentos obturadores apresentaram baixa toxicidade, mas ativaram os macrófagos de modo distinto. A ativação pelo Sealapex Xpress foi caracterizada pela inibição do TNF-a e indução da IL-10, enquanto o Real Seal XT induziu somente IL-6.


Subject(s)
Root Canal Filling Materials , Materials Testing , Calcium Hydroxide , Salicylates , Inflammation Mediators , Macrophages
9.
Salud pública Méx ; 63(1): 27-33, Jan.-Feb. 2021. tab
Article in English | LILACS-Express | LILACS | ID: biblio-1395135

ABSTRACT

Abstract: Objective: The aim of this study is to evaluate the prevalence of T. pallidum infection markers in HIV-positive individuals receiving highly active antiretroviral therapy (ART) in the Mexico City HIV/AIDS Program, as well as predictive characteristics. Materials and methods: The reverse serologic algorithm method was used for the T. pallidum diagnosis, and applied to 2 383 HIV-positive individuals. Sociodemographic characteristics, sexual practices, previous syphilis diagnosis, and length of antiretroviral treatment, were evaluated. Variables significantly associated with syphilis markers were analyzed using a logistic regression model. Results: Prevalence of "active or resolved" and "probable active" infection markers were 44.2 and 28.8%, respectively. Predictive factors were: Clínica Especializada Condesa Iztapalapa (CECI), previous syphilis diagnosis, men in who have sex with men (MSM), and receptive sex practices. Conclusions: The prevalence of T. pallidum infection markers was the highest ever reported in Mexico, and was related to specific sexual practices as well as previous syphilis diagnosis, elements which require preventive measures in the Mexico City HIV/AIDS Program.


Resumen: Objetivo: Evaluar las prevalencias de marcadores de infección por T. pallidum en personas que viven con VIH y reciben tratamiento antirretroviral en el Programa de VIH/SIDA de la Ciudad de México, así como sus características asociadas. Material y métodos: Se siguió el método del algoritmo reverso para el diagnóstico de T. pallidum aplicado a 2 383 individuos VIH positivos, quienes contestaron un cuestionario sobre características sociodemográficas, prácticas sexuales, diagnóstico previo de sífilis y tiempo de tratamiento antirretroviral. Las variables significativamente asociadas con los marcadores de sífilis se analizaron mediante un modelo de regresión logística. Resultados: Las prevalencias de marcadores de infección "activa o resuelta" y "probablemente activa" fueron 44.2 y 28.8%, respectivamente. Las características asociadas con los marcadores fueron Clínica Especializada Condesa Iztapalapa (CECI), diagnóstico previo de infección por sífilis, hombres que tienen sexo con hombres (HSH) y prácticas sexuales receptivas. Conclusiones: Las prevalencias de marcadores de infección por T. pallidum fueron altas y estuvieron relacionadas con prácticas sexuales específicas y con el diagnóstico previo de sífilis, características que requieren medidas preventivas dentro del programa.

10.
Gac. méd. Méx ; 156(6): 569-579, nov.-dic. 2020. tab, graf
Article in Spanish | LILACS | ID: biblio-1249969

ABSTRACT

Resumen Introducción: México tiene la mortalidad más alta a 30 días por infarto agudo de miocardio (IAM), el cual constituye una de las principales causas de mortalidad en el país: 28 % versus 7.5 % del promedio de los países de la Organización para la Cooperación y el Desarrollo Económicos. Objetivo: Establecer las rutas críticas y las estrategias farmacológicas esenciales interinstitucionales para la atención de los pacientes con IAM en México, independientemente de su condición socioeconómica. Método: Se reunió a un grupo de expertos en diagnóstico y tratamiento de IAM, representantes de las principales instituciones públicas de salud de México, así como las sociedades cardiológicas mexicanas, Cruz Roja Mexicana y representantes de la Sociedad Española de Cardiología, con la finalidad de optimizar las estrategias con base en la mejor evidencia existente. Resultados: Se diseñó una guía de práctica clínica interinstitucional para el diagnóstico temprano y tratamiento oportuno del IAM con elevación del segmento ST, siguiendo el horizonte clínico de la enfermedad, con la propuesta de algoritmos que mejoren el pronóstico de los pacientes que acuden por IAM a los servicios de urgencias. Conclusión: Con la presente guía práctica, el grupo de expertos propone universalizar el diagnóstico y tratamiento en el IAM, independientemente de la condición socioeconómica del paciente.


Abstract Introduction: Mexico has the highest 30-day acute myocardial infarction (AMI) mortality rate: 28% versus 7.5% on average for the OECD countries, and it constitutes one of the main causes of mortality in the country. Objective: To establish critical pathways and essential interinstitutional pharmacological strategies for the care of patients with AMI in Mexico, regardless of their socioeconomic status. Method: A group of experts in AMI diagnosis and treatment, representatives of the main public health institutions in Mexico, as well as the Mexican cardiology societies, the Mexican Red Cross and representatives of the Spanish Society of Cardiology, were brought together in order to optimize strategies based on the best existing evidence. Results: An interinstitutional clinical practice guideline was designed for early diagnosis and timely treatment of AMI with ST elevation, following the clinical horizon of the disease, with the proposal of algorithms that improve the prognosis of patients who attend the emergency services due to an AMI. Conclusion: With these clinical practice guidelines, the group of experts proposes to universalize AMI diagnosis and treatment, regardless of patient socioeconomic status.


Subject(s)
Humans , Consensus , ST Elevation Myocardial Infarction/diagnosis , Societies, Medical , Spain , Biomarkers/blood , Myocardial Reperfusion/methods , Thrombolytic Therapy/methods , Cause of Death , Electrocardiography , Percutaneous Coronary Intervention/methods , ST Elevation Myocardial Infarction/rehabilitation , ST Elevation Myocardial Infarction/blood , Cardiac Rehabilitation , COVID-19/prevention & control , Mexico
11.
Bol. méd. Hosp. Infant. Méx ; 77(3): 149-152, may.-jun. 2020. tab
Article in English | LILACS | ID: biblio-1124283

ABSTRACT

Abstract Background: Weeksella virosa is one of the two species of the genus Weeksella. Clinical disease due to this bacterium in humans is rare, for which only nine cases have been reported in the literature. Case report: A 4-year-old male patient was diagnosed with a left orbit rhabdomyosarcoma Stage III and was admitted to a northeast third level referral center in Mexico. Aerobic, non-pigmented, Gram-negative rod was isolated from a blood culture. W. virosa was identified by Sensititre™ ARIS. This organism has been described in cases of spontaneous bacterial peritonitis, sepsis, pneumonia, ventriculitis, and urinary tract infection. Conclusions: Clinicians should consider the diagnosis of W. virosa bacteremia in cases involving immunocompromised patients with oral lesions, although it is infrequent. To the best of our knowledge, this is the first clinical report of W. virosa bacteremia described in an immunocompromised pediatric patient.


Resumen Introducción: Weeksella virosa es una de las dos especies del género Weeksella. En los humanos, los reportes de infección por este microorganismo son raros. Solo se han reportado nueve casos en la literatura. Caso clínico: Paciente masculino de 4 años con diagnóstico de rabdomiosarcoma embrionario de órbita izquierda en estadio III, que fue atendido en un hospital de tercer nivel en el noreste de México. Se realizó un hemocultivo, a partir del cual se aisló un bacilo gramnegativo aerobio, no pigmentado. Se identificó W. virosa mediante Sensititre™ ARIS. Este microorganismo ha sido descrito en casos de peritonitis bacteriana espontánea, sepsis, neumonía, ventriculitis e infección del tracto urinario. Conclusiones: Aunque los casos de bacteriemia por W. virosa son raros, los clínicos deben considerar este agente en pacientes inmunocomprometidos con lesiones orales. Hasta donde se conoce, este es el primer caso que se describe de bacteriemia por W. virosa en un paciente pediátrico inmunocomprometido.


Subject(s)
Child , Child, Preschool , Humans , Male , Bacteremia , Rhabdomyosarcoma, Embryonal , Sepsis , Flavobacteriaceae , Bacteremia/diagnosis , Rhabdomyosarcoma, Embryonal/diagnosis , Sepsis/diagnosis
12.
Braz. dent. j ; 30(6): 599-606, Nov.-Dec. 2019. tab, graf
Article in English | LILACS | ID: biblio-1055458

ABSTRACT

Abstract The aim of this study was to evaluate the subcutaneous connective tissue response of isogenic mice after implantation of different glass ionomer-based cements (EQUIA® Forte Fil, EQUIA® Fil and Ketac™ Universal Aplicap™). Eighty-seven isogenic BALB/c mice were allocated in 12 groups, 9 were considered as experimental groups (Ketac, E. Fil and E. Forte at 7, 21 and 63 days) and 3 controls (empty polyethylene tubes at 7, 21 and 63 days). After the experimental periods, the subcutaneous connective tissue surrounding the implanted material was removed and subjected to histotechnical processing and staining with hematoxylin and eosin. A histopathological description of the tissue reaction surrounding each material and a semi-quantitative analysis of collagen fiber formation and inflammatory infiltrate were performed. Additionally, the thickness of the granulomatous tissue in contact with each material was measured. Data were analyzed statistically (α=0.05) by the Kruskal-Wallis test, followed by Dunn post-test. Initially, the collagen fiber formation was not different among all the tested materials (p>0.05) but was different at 21 days with the control group presenting the most advanced stage of collagen fiber formation. At 63 days, EQUIA® Forte Fil group showed the most advanced stage of collagen fiber formation, compared to EQUIA® Fil group (p<0.05). The inflammatory infiltrate was not different among the tested materials in any experimental period (p>0.05). The thickness of the granulomatous tissue was greater in the E. Forte group, compared to control in all periods. All glass ionomer-based cements showed tissue compatibility, according to the evaluated parameters.


Resumo O objetivo deste estudo foi avaliar a resposta subcutânea do tecido conjuntivo de camundongos isogênicos após o implante de diferentes cimentos à base de ionômero de vidro (EQUIA® Forte Fil, EQUIA® Fil e Ketac ™ Universal Aplicap ™). Oitenta e sete camundongos isogênicos BALB/c foram alocados em 12 grupos, 9 como grupos experimentais (Ketac, E. Fil e E. Forte aos 7, 21 e 63 dias) e 3 controles (tubos de polietileno vazios aos 7, 21 e 63 dias). Após os períodos experimentais, o tecido conjuntivo subcutâneo ao redor do material implantado foi removido e submetido ao processamento histotécnico e coloração com hematoxilina e eosina. Uma descrição histopatológica da reação tecidual envolvendo cada material e uma análise semi-quantitativa da fibrose e infiltrado inflamatório foram realizadas. Além disso, foi realizada a mensuração da espessura do tecido granulomatoso em contato com cada material. Os dados foram analisados estatisticamente (α=0,05) pelo teste de Kruskal-Wallis, seguido do pós-teste de Dunn. Inicialmente, a fibrose não foi diferente entre todos os materiais testados (p>0,05), mas foi diferente aos 21 dias, com o grupo controle apresentando o estágio mais avançado de fibrose. Aos 63 dias, o grupo EQUIA® Forte Fil apresentou o estágio mais avançado de fibrose, comparado ao grupo EQUIA® Fil (p<0,05). O infiltrado inflamatório não foi diferente entre os materiais testados em nenhum período experimental (p>0,05). A espessura do tecido granulomatoso foi maior no grupo E. Forte, comparado ao controle em todos os períodos. Todos os cimentos à base de ionômero de vidro apresentaram compatibilidade tecidual, de acordo com os parâmetros avaliados.


Subject(s)
Animals , Rabbits , Acrylic Resins , Glass Ionomer Cements , Materials Testing , Silicon Dioxide , Mice, Inbred BALB C
13.
Arch. cardiol. Méx ; 89(2): 117-122, Apr.-Jun. 2019. graf
Article in Spanish | LILACS | ID: biblio-1142172

ABSTRACT

Resumen Antecedentes: La estenosis aórtica es una de las valvulopatías más frecuentes en el paciente mayor. Su tratamiento es la cirugía de corazón, sin embargo, muchos pacientes no se benefician de este tratamiento por considerarse de alto riesgo quirúrgico o inoperables. Para estos últimos pacientes se desarrolló el implante de válvula aórtica transcatéter (TAVI). Objetivo: Dar a conocer la factibilidad y seguridad de otras vías de acceso para la implantación de válvulas aórticas transcatéter y que además se puede realizar en el laboratorio de hemodinámica. Además de un rápido crecimiento en tecnología y conocimientos, actualmente ya se tiene mucha experiencia con TAVI. Metodología: Una de las limitantes es el diámetro de los accesos vasculares femorales, subclavio y axilar. Es por esto por lo que se buscan otros accesos como el aórtico directo, a pesar del carácter invasivo de la minitoracotomía y aortotomía es técnicamente factible, familiar y fácil de aprender para los cirujanos cardíacos. Resultado: Se ha asociado con resultados favorables y una menor tasa de complicaciones (sangrado, riesgo de lesión miocárdica) y menor duración de la estancia en la Unidad de Cuidados Intensivos en comparación con la cirugía o el acceso transapical. Conclusión: Nuestro centro implantó con éxito la válvula aórtica autoexpandible Evolut vía aórtica directa por presentar una disección en la aorta transversa con posibilidades de embolización.


Abstract Background: Aortic stenosis is one of the most frequent valvulopathies in the elderly patient. The treatment for aortic stenosis is heart surgery, however many patients do not benefit from this treatment because they are considered to be at high surgical or inoperable risk. Transcatheter aortic valve (TAVI) was developed for these patients. Objective: To make known the feasibility and safety of other access routes for the implantation of transcatheter aortic valves and that it can also be performed in the hemodynamic laboratory. In addition to rapid growth in technology and know-how, TAVI is already very experienced. Methodology: One of the limitations is the diameter of the femoral, subclavian, and axillary vascular accesses. This is why other approaches such as the direct aortic approach are sought, despite the invasive nature of mini-thoracotomy and aortotomy is technically feasible, familiar and easy to learn for cardiac surgeons. Results: In addition, it has been associated with favorable outcomes and a lower rate of complications (bleeding, risk of myocardial injury) and shorter length of stay in the Intensive Care Unit compared to surgery or transapical access. Conclusion: Our center successfully implanted the self-expandable aortic valve Evolut via direct aortic for presenting a dissection in transverse aorta with possibilities of embolization.


Subject(s)
Aged , Female , Humans , Aortic Valve/surgery , Aortic Valve Stenosis/surgery , Heart Valve Prosthesis , Transcatheter Aortic Valve Replacement , Prosthesis Design , Mexico
14.
Rev. MVZ Córdoba ; 24(1): 7137-7144, ene-abr. 2019. tab, graf
Article in English | LILACS | ID: biblio-1013273

ABSTRACT

ABSTRACT Objective. Isolate, identify and molecularly characterize pathogenic Cryptococcus isolates for humans from environmental and clinical samples from the city of Cúcuta. Materials and methods. A total of 1300 samples were collected from 446 trees of 10 different species in 10 public areas of Cúcuta. Concomitantly, clinical isolates of Cryptococcus neoformans were obtained (June 2016-June 2017). The samples were cultivated in Guizottia abysinica seed medium and were then biochemically identified and characterized by PCR fingerpinting and RFLP of the URA5 gene. Results. C. neoformans displayed an environmental prevalence of 4.3% (19 positive individuals), and that of C. gattii was 0.2% (1 positive individual); this yielded a total of 20 Cryptococcus-positive trees and 21 isolates (two from the same individual). Santander Park registered 47.6% of the global prevalence (10/21 isolates), followed by La Victoria Park with 23.8% (5/21 isolates), corresponding to C. neoformans. One C. gattii isolate was collected from a Ficus benjamina tree located in Mercedes Ábrego Park. Genotypic analysis revealed the presence of C. neoformans var. grubii VNI in 85.7% of environmental isolates as well as 100% of clinical isolates. VNII and VGII molecular types represented 9.5% and 4.8% of the environmental isolates, respectively. Conclusions. The longitudinal sampling of previously reported environmental niches of the fungus reveals its presence and suggests that permanent monitoring is required both in the environment and in patients, especially in endemic areas of the city.


RESUMEN Objetivo. Aislar, identificar y caracterizar molecularmente aislamientos de Cryptococcus patógenos para humanos a partir de muestras ambientales y clínicas de la ciudad de Cúcuta. Materiales y métodos. Se recolectaron 1300 muestras de 446 árboles de 10 especies diferentes, en 10 zonas públicas de Cúcuta. Concomitantemente, se obtuvieron aislados clínicos de Cryptococcus neoformans (junio de 2016-junio de 2017). Se realizó cultivo en agar semillas de Guizottia abysinica, posterior identificación bioquímica y caracterización genética mediante PCR-huella Digital y RFLP-URA5. Resultados. Se determinó prevalencia ambiental para C. neoformans de 4.3% (19 individuos positivos) y C. gattii de 0.2% (1 individuo positivo), para un total de 21 aislados y 20 árboles positivos. El parque Santander registró el 47.6% de la prevalencia global (10/21 aislados), seguido del parque La Victoria con 23.8% (5/21 aislados), correspondientes a C. neoformans. Se obtuvo un aislado de C. gattii en un individuo Ficus benjamina del parque Mercedes Ábrego. El análisis genotípico reveló presencia de C. neoformans var. grubii VNI en el 85.7% de los aislados ambientales, así como en el 100% de los clínicos, seguido de VNII y VGII en 9.5% y 4.8% de los aislados ambientales, respectivamente. Conclusiones. El muestreo longitudinal de los nichos ambientales previamente reportados del hongo revela su presencia y sugiere que se requiere una vigilancia permanente tanto en el medio ambiente como en los pacientes, especialmente en las zonas endémicas de la ciudad.


Subject(s)
Cryptococcosis , Cryptococcus neoformans , Genotype
15.
Int. j. odontostomatol. (Print) ; 12(4): 395-400, dic. 2018. tab, graf
Article in English | LILACS | ID: biblio-975763

ABSTRACT

ABSTRACT: The aim of this study was to evaluate the adhesion and initial colonization of S. mutans on the surface of novel composite resins during three experimental periods. Biofilms were formed on specimens of Enamel Plus HRI (Hri), FiltekTM Silorane (Si), Tetric EvoCeram® Bulk Fill (Te), KaloreTM (K), and FiltekTM Z250 (Z) (n=4/experimental period). After 4, 8 and 24 hours, the specimens were assessed for bacterial colony forming unit (CFU/mm2) levels and scanned by electron microscopy. All material surfaces showed a similar susceptibility to bacterial adhesion at 4 hours (p>0.05). The amount of microorganisms in the formed biofilms increased at 8 hours for all groups (p<0.05) and decreased at 24 hours only for Te and Z groups (p<0.05). After 24 h, the K group showed higher microorganism counts compared to the other groups. All composite resins evaluated were susceptible to adhesion by streptococci. However, bacteria attachment was not sufficient to maintain S. mutans colonization on Tetric EvoCeram® Bulk Fill and FiltekTM Z250 composites. Composite K presented the highest mean values for bacterial adhesion. Also, it was observed that the composition of resins could interfere with colonization mechanisms.


RESUMEN: El objetivo de este estudio fue evaluar la adhesión y la colonización inicial de S. mutans en la superficie de nuevas resinas compuestas durante tres períodos experimentales. Las biopelículas se formaron en muestras de Enamel Plus HRI (Hri), FiltekTM Silorane (Si), Tetric EvoCeram® Bulk Fill (Te), KaloreTM (K) y FiltekTM Z250 (Z) (n = 4 / período experimental). Después de 4, 8 y 24 horas, las muestras se evaluaron para determinar los niveles de la unidad formadora de colonias bacterianas (UFC / mm2) y se escanearon por microscopía electrónica. Todas las superficies del material mostraron una susceptibilidad similar a la adhesión bacteriana a las 4 horas (p> 0,05). La cantidad de microorganismos en las biopelículas formadas aumentó a las 8 horas para todos los grupos (p <0,05) y disminuyó a las 24 horas solo para los grupos Te y Z (p <0,05). Después de 24 horas, el grupo K mostró mayores recuentos de microorganismos en comparación con los otros grupos. Todas las resinas compuestas evaluadas fueron susceptibles a la adhesión por estreptococos. Sin embargo, la unión de bacterias no fue suficiente para mantener la colonización de S. mutans en los compuestos Tetric EvoCeram® Bulk Fill y FiltekTM Z250. El compuesto K presentó los valores medios más altos para la adhesión bacteriana. Además, se observó que la composición de las resinas podría interferir con los mecanismos de colonización.


Subject(s)
Humans , Dental Caries , Dental Plaque , Streptococcus mutans , Microscopy, Electron , Analysis of Variance , Microbiological Techniques , Composite Resins/chemistry , Biofilms
16.
Rev. sanid. mil ; 72(5/6): 317-323, sep.-dic. 2018. tab, graf
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1020881

ABSTRACT

Resumen Introducción La hipertensión arterial sistémica refractaria es la presión arterial en el consultorio por encima de la meta apropiada a pesar del uso de tres o más antihipertensivos, uno de los cuales es un diurético; la denervación renal por ablación por radiofrecuencia es un tratamiento para este padecimiento, el cual es efectivo y seguro. Consideramos que la denervación disminuye el tono del sistema nervioso autónomo a nivel renal (eje renina angiotensina aldosterona), por lo que el resultado será la disminución de la presión arterial sin afectar la variabilidad de la frecuencia cardiaca. Objetivo Determinar si existe modificación en la variabilidad de la frecuencia cardiaca en pacientes con hipertensión arterial sistémica refractaria que son tratados mediante denervación renal por radiofrecuencia con catéter. Material y métodos Estudio observacional, descriptivo y analítico de pacientes con hipertensión arterial sistémica refractaria que fueron tratados mediante ablación renal por radiofrecuencia con catéter. Se midió la variabilidad de la frecuencia cardiaca en el dominio temporal y frecuencial, antes y dos meses después del procedimiento. El análisis estadístico de resultados se hizo con la prueba t de Student para muestras relacionadas. Resultados Fueron elegibles nueve pacientes, sólo se incluyeron seis pacientes con hipertensión arterial sistémica refractaria tratados mediante ablación renal por radiofrecuencia en el dominio temporal para la desviación estándar de los intervalos NN (SDNN), se observó un incremento estadísticamente no significativo (7 ms, p = 0.58). Conclusión En los seis pacientes con hipertensión arterial sistémica refractaria tratados mediante ablación renal por radiofrecuencia se observó, dos meses posteriores al procedimiento, que la variabilidad de la frecuencia cardiaca en el dominio temporal para la desviación estándar de los intervalos NN (SDNN) se incrementó 7 ms, siendo estadísticamente no significativo (p = 0.58).


Abstract Introduction Refractory systemic arterial hypertension is the blood pressure above the appropriate goal despite the use of three or more antihypertensive drugs, one of which is a diuretic; renal denervation by radiofrequency ablation, is a treatment for this condition, which is effective and safe. We consider that denervation decreases the tone of the autonomic nervous system at the renal level (renin angiotensin aldosterone axis), so that the result will be a decrease in blood pressure without affecting the variability of the heart rate. Objective To determine if there is a change in the variability of heart rate in patients with refractory systemic arterial hypertension who are treated by radiofrequency renal denervation with catheter. Material and methods Observational, descriptive and analytical study of patients with refractory systemic arterial hypertension who were treated by radiofrequency renal ablation with catheter. The variability of the heart rate in the temporal and frequency domain was measured before and two months after the procedure. The statistical analysis of results was by Student's t-test for related samples. Results Nine patients were eligible, only six patients with refractory systemic arterial hypertension treated by radiofrequency renal ablation were included, in the domain temporal domain for the standard deviation of the NN intervals (SDNN), a statistically non-significant increase was observed (7 ms, p = 0.58). Conclusion In the six patients with refractory systemic arterial hypertension treated by radiofrequency renal ablation, it was observed two months after the procedure, that the variability of the heart rate in the time domain for the standard deviation of the NN intervals (SDNN), it increased 7 ms, being statistically non-significant (p = 0.58).

17.
Rev. cuba. cir ; 57(3): e682, jul.-set. 2018. tab
Article in Spanish | LILACS | ID: biblio-985518

ABSTRACT

Introducción: El síndrome adherencial es la causa más frecuente de obstrucción de intestino delgado. La laparotomía es el abordaje estándar. El avance de la cirugía mínimamente invasiva hace posible la resolución de cuadros obstructivos por laparoscopia. Objetivo: Analizar el abordaje laparoscópico de la obstrucción intestinal y compararlo con la vía abierta. Método: Análisis retrospectivo de los pacientes tratados de obstrucción intestinal aguda mediante laparoscopia en nuestro hospital desde 2012 hasta 2016. Se utilizó como referencia un grupo de pacientes tratados desde 2002 hasta 2005, cuando sólo se usaba el abordaje abierto. Se analizaron datos demográficos, riesgo quirúrgico, comorbilidades, métodos diagnósticos y complicaciones (Clavien). Resultados: De los 134 pacientes intervenidos de obstrucción intestinal aguda, se inició un abordaje laparoscópico en 47 (35 pr ciento). Por esta vía sólo se completaron 32 pacientes (68 por ciento). La tasa de conversión fue del 32 por ciento, estos pacientes fueron eliminados del estudio. En el grupo de referencia se analizaron al azar 32 pacientes. Ambos grupos son comparables. El grupo tratado con abordaje laparoscópico tuvo un 9 por ciento de complicaciones y un 3 por ciento de reintervenciones, con una sola lesión inadvertida. El grupo laparoscópico tuvo un 12,5 por ciento de reintervenciones, todas por evisceración, pero tuvo una lógica mayor tasa de resecciones intestinales. No hubo mortalidad hospitalaria. Conclusión: Los resultados en los pacientes en que se ha completado la cirugía por laparoscopia se comparan favorablemente con los del abordaje abierto en un grupo histórico homogéneo de referencia, y sin el riesgo añadido de evisceración(AU)


Introduction: Adherence syndrome is the most frequent cause of small bowel obstruction. Laparotomy is the standard approach. The progress of minimally invasive surgery makes it possible to resolve obstructive frames by laparoscopy. Objective: To analyze the laparoscopic approach for intestinal obstruction and compare it with the open pathway. Method: Retrospective analysis of patients treated for acute intestinal obstruction by laparoscopy in our hospital, from 2012 to 2016. A group of patients treated from 2002 to 2005 were used as reference, when only the open approach was used. We analyzed demographic data, surgical risk, comorbidities, diagnostic methods and complications (Clavien). Results: Within the 134 patients operated for acute intestinal obstruction, a laparoscopic approach was started in 47 (35 percent). Only 32 patients (68 percent) were completed in this way. The conversion rate was 32 percent, these patients were eliminated from the study. In the reference group, 32 patients were randomly analyzed. Both groups are comparable. The group treated with laparoscopic approach had 9 por ciento complications and 3 percent reoperations, with a single unexpected lesion. The laparoscopic group had 12.5 of reintervention, all due to evisceration, but had a higher rate of intestinal resections. There was no hospital mortality. Conclusion: In patients who have completed laparoscopic surgery, the results are compared favorably with those of the open approach in a homogeneous historical reference group, and without the added risk of evisceration(AU)


Subject(s)
Humans , Morbidity Surveys , Laparoscopy/methods , Conversion to Open Surgery/statistics & numerical data , Intestinal Obstruction/surgery , Retrospective Studies , Minimally Invasive Surgical Procedures/methods
18.
Rev. sanid. mil ; 72(3/4): 231-239, may.-ago. 2018. tab, graf
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1004494

ABSTRACT

Resumen El oxígeno hiperbárico (HBO2) es un tratamiento útil para enfermedades isquémicas; sin embargo, como tratamiento coadyuvante en el infarto al miocardio (IAM), existe muy poca experiencia a nivel mundial; ha sido utilizado en algunos trabajos de investigación como tratamiento único en una sola exposición en el contexto de un infarto agudo con elevación del segmento ST (IAMCEST) y adicional a la trombólisis. Nuestro estudio describe la factibilidad y seguridad de dosis continuas de tratamiento con HBO2 después de un infarto al mejorar la función del ventrículo izquierdo. Objetivo El objetivo de este trabajo es describir la experiencia y la seguridad de las dosis de HBO2 en el paciente con IAMCEST llevado a angioplastia primaria para mejorar la función del ventrículo izquierdo. Material y métodos Se reunieron 24 pacientes aleatorizados en dos grupos: 13 en el de casos y 11 controles. Ambos grupos fueron llevados a angioplastia primaria y tratamiento convencional. Se valoró la función ventricular izquierda con SPECT CT; el grupo de casos recibió 15 sesiones repetidas de 90 minutos de isopresión a 2.0 ATA. Resultados Los dos grupos eran de similares características; ingresaron al hospital con un IAMCEST y fueron llevados a angioplastia primaria, aleatorizados en dos grupos; el de casos fue llevado a la cámara hiperbárica para recibir dosis diarias por 15 días de HBO2 a 2 ATA por 90 minutos de isopresión. No se presentaron durante el tratamiento con oxígeno hiperbárico complicaciones cardiovasculares: reinfarto, sangrados, descontrol hipertensivo, arritmias ni datos de insuficiencia cardiaca. En cuanto a complicaciones propias de la cámara hiperbárica, sólo un paciente presentó claustrofobia importante. Además, se observó un beneficio adicional al tratamiento convencional del IAMCEST: la fracción de expulsión del ventrículo izquierdo (FEVI) en el IAM anteroseptal mejoró significativamente en el grupo de casos. Conclusiones El oxígeno hiperbárico a dosis continuas es seguro y factible como tratamiento adicional al paciente con IAMCEST llevado a angioplastia primaria, además de mejorar la función ventricular izquierda en los infartos extensos.


Abstract Hyperbaric oxygen (HBO2) is a useful treatment for ischemic diseases; however, as an adjuvant treatment in myocardial infarction (MI), there is very little experience worldwide. It has been used in some research work as a single treatment in a single exposure in the context of an ST-segment elevation myocardial infarction (STEMI) and in addition to thrombolysis. Our study describes the feasibility and safety of continuous doses of HBO2 after a heart attack by improving left ventricular function. Objective The objective of this study is to describe the experience and safety of HBO2 doses in the patient with STEMI taken to primary angioplasty to improve left ventricular function. Material and methods 24 randomized patients were collected and divided into two groups: 13 in the case group and 11 control patients. Both groups were taken to primary angioplasty and conventional treatment. Left ventricular function was assessed with SPECT CT; the case group received 15 repeated 90-minute sessions of isopressure at 2.0 ATA. Results The two groups were similar in characteristics; they were admitted to the hospital with an STEMI, taken to primary angioplasty, randomized into two groups. The group of cases was taken to the hyperbaric chamber to receive daily doses of HBO2 for 15 days at 2 ATA for 90 minutes of isopressure. There were no cardiovascular complications during the treatment with hyperbaric oxygen: reinfarction, bleeding, hypertensive disorder, arrhythmias or heart failure data. Complications typical of the hyperbaric chamber: only one patient presented significant claustrophobia. In addition to the benefits of the conventional treatment of STEMI, the left-ventricular ejection fraction (LVEF) in anteroseptal MI was significantly improved in the group of cases. Conclusions Continuous-dose hyperbaric oxygen is safe and feasible as an additional treatment for patients with STEMI taken to primary angioplasty, in addition to improving left ventricular function in extensive heart attacks.

19.
Rev. Cient. CRO-RJ (Online) ; 3(1): 8-15, Jan.-Apr. 2018.
Article in English | LILACS, BBO | ID: biblio-1021064

ABSTRACT

Objective: The objective of this study was to evaluate the tissue response and expression of matrix metalloproteinases (MMP) -2 and -9 to resinous and glass ionomer cements in direct contact with the subcutaneous connective tissue. Methods: RelyXTM Unicem resinous cement (RC; n=30), KetacTM Cem Easymix glass ionomer cement (GI; n=30), and polyethylene empty tubes (control; n=30) were implanted in the dorsal subcutaneous tissue of isogenic BALB/c mice, and the tissues were biopsied after 7, 21, and 63 days for histological analysis. The inflammatory cells and fibroblasts were counted, and the fibrous capsule thickness was measured. MMP -2 and MMP-9 expression levels were investigated by immunohistochemistry. Data were analyzed statistically (significance level=5%). Results: We found that RC induced a low inflammation at day 7 and 21, which was increased at day 63 (p<0.05). GI induced a more intense mononuclear inflammatory response at day 7 and 21 (p<0.05), which was reduced at day 63 to levels similar to the control (p>0.05). The fibrous capsule thickness was thin for RC, GI, and control (p>0.05).MMP-2 was detected early for GI and RC and decreased afterwards. MMP-9 presented a similar pattern for GI, whereas the MMP -9 expression was late for RC. Conclusion: Resinous cementRelyXTM Unicem induced an inflammatory response and late MMP -9 expression in the subcutaneous connective tissue that was different from that induced by KetacTM Cem Easymixglass ionomer cement.


Objetivo: Avaliar a resposta tecidual e a expressão de metaloproteinases da matriz (MMP) -2 e -9 frente a um cimento resinoso e um cimento ionomérico, após implantação no tecido conjuntivo subcutâneo de camundongos. Métodos: O cimento resinoso RelyXTM Unicem (CR; n=30), o cimento ionomérico KetacTM Cem Easymix (CI; n=30) e tubo de polietileno vazio (controle; n=30) foram implantados no tecido subcutâneo dorsal de camundongos isogênicos BALB/c e os tecidos removidos para análise histológica após 7, 21 e 63 dias. Foram analisadas a resposta celular local, por meio da contagem de células inflamatórias e a espessura da cápsula fibrosa. A expressão de MMP -2 e -9 foi investigada por meio de imunohistoquímica. Os dados foram submetidos à análise estatística (α=5%). Resultados: Foi observado que CR induziu uma inflamação leve aos 7 e 21 dias com aumento do número de células inflamatórias aos 63 dias (p<0,05). CI induziu uma resposta inflamatória mononuclear mais intensa aos 7 e 21 dias (p<0,05), com redução do infiltrado aos 63 dias, semelhante ao observado no controle (p>0,05). Em todos os grupos a espessura da cápsula foi considerada fina (p>0,05). MMP -2 foi detectada em períodos precoces para CR e CI, com diminuição com o passar do tempo. MMP -9 apresentou um padrão semelhante ao controle para o CI, enquanto para o CR houve aumento com o passar do tempo. Conclusão: O cimento resinoso RelyXTM Unicem induziu uma resposta inflamatória e a expressão de MMP -9 mais tardia no tecido conjuntivo subcutâneo que foi diferente da resposta induzida pelo cimento ionomérico KetacTM Cem Easymix.


Subject(s)
Connective Tissue , Resin Cements , Matrix Metalloproteinases , Dental Cements , Glass Ionomer Cements
20.
Rev. sanid. mil ; 72(2): 98-104, mar.-abr. 2018. tab, graf
Article in Spanish | LILACS | ID: biblio-991627

ABSTRACT

Resumen Introducción El implante de la válvula aórtica transcatéter (TAVI) es un tratamiento de mínima invasión e innovador con buenos resultados, para pacientes con estenosis aórtica de riesgo quirúrgico intermedio o alto; sin embargo, la gran mayoría de los pacientes son de edad avanzada y con múltiples comorbilidades que condicionan un aumento de la mortalidad y en muchos casos de las complicaciones. Un punto crucial y determinante para una buena evolución es el papel del equipo de corazón de una institución, ya que un equipo incompleto o con poca experiencia conlleva a una mala selección de pacientes. En nuestra institución el equipo de corazón pasó a ser un equipo multidisciplinario integrado por varias especialidades para la valoración integral de los pacientes. Material y Métodos Se llevó a cabo una cohorte de 36 pacientes en el Hospital Central Militar desde septiembre del 2013 a octubre del 2017. Se reunieron 36 pacientes con estenosis aórtica y tratados con TAVI; los primeros 17 pacientes fueron evaluados por un cirujano cardiovascular, dos cardiólogos intervencionistas, y dos cardiólogos clínicos. Posteriormente se evaluaron 19 pacientes en donde se incluyó en el equipo multidisciplinario a una geriatra, neumólogo, neurólogo, entre otras especialidades. Resultados De los 36 pacientes en total que fueron llevados a TAVI, los primeros 17 pacientes fueron seleccionados por el equipo de corazón desde el inicio del programa hasta el 2015 (47.2%) y los últimos 19 pacientes (del 2015 a la fecha) valorados por el equipo multidisciplinario (52.7%). En el primer grupo fallecieron durante el seguimiento a un año, por muerte de causa no cardiaca, ocho de 17 pacientes (47%) y en el segundo grupo, dos pacientes de 19 (10.5%), una muerte cardiaca y otra no cardiaca. Conclusiones Los resultados de un programa para TAVI están basados en tres puntos fuertes: las instalaciones, la formación del equipo de corazón y la experiencia del equipo implantador de válvulas; sin embargo, nosotros formamos un equipo multidisciplinario integrado por el equipo de corazón y otro personal de salud trascendental en la selección y seguimiento de los pacientes con mejores resultados a corto y largo plazo.


Abstract Introduction The implantation of the transcatheter aortic valve (TAVI) is a minimally invasive and innovative treatment with good results for patients with aortic stenosis of intermediate or high surgical risk; However, the vast majority of patients are elderly and have multiple co-morbidities that lead to increased mortality and in many cases to complications. A crucial and determining point for a good evolution is the role of the heart team of an institution, since an incomplete team or with little experience leads to a poor selection of patients. In our institution, the heart team became a multidisciplinary team composed of several specialties for the comprehensive assessment of patients. Material and Methods A cohort of 36 patients was carried out at the Central Military Hospital from September 2013 to October 2017. Thirty-six patients with aortic stenosis and treated with TAVI were met; The first 17 patients were evaluated by a cardiovascular surgeon, two interventional cardiologists, and two clinical cardiologists. Subsequently, a geriatrician, a pulmonologist, and a neurologist were included in the multidisciplinary team, among other specialties. Results Of the 36 patients in total who were taken to TAVI, the first 17 patients selected by the heart team from the beginning of the program until 2015 (47.2%) and the last 19 patients (from 2015 to date) valued by the multidisciplinary team (52.7%). In the first group, they died during the follow-up at one year, 8 of 17 patients (47%) and in the second group, 2 patients of 19 (10.5%). Conclusions The results of a program for TAVI are based on three strengths, the facilities, the training of the heart team and the experience of the valve implantation team, however, we form a multidisciplinary team composed of the heart team and another transcendental health personnel in the selection and follow-up of patients.

SELECTION OF CITATIONS
SEARCH DETAIL